Abeona Therapeutics Inc (ABEO.OQ)
ABEO.OQ on NASDAQ Stock Exchange Capital Market
8.54USD
7 Dec 2018
8.54USD
7 Dec 2018
Change (% chg)
$0.39 (+4.79%)
$0.39 (+4.79%)
Prev Close
$8.15
$8.15
Open
$8.08
$8.08
Day's High
$8.90
$8.90
Day's Low
$7.86
$7.86
Volume
380,743
380,743
Avg. Vol
199,909
199,909
52-wk High
$22.00
$22.00
52-wk Low
$6.94
$6.94
About
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel gene therapies for life-threatening rare genetic diseases. The Company’s lead programs include ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and EB-101 (gene-corrected skin... (more)
Overall
| Beta: | 2.29 |
| Market Cap(Mil.): | $713.08 |
| Shares Outstanding(Mil.): | 40.29 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ABEO.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 92.25 | 33.63 |
| EPS (TTM): | -0.60 | -- | -- |
| ROI: | -29.33 | 0.28 | 15.02 |
| ROE: | -30.75 | 0.94 | 16.60 |
Estimates